Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib

Detalles Bibliográficos
Autores principales: Tamura, Kazuo, Nukiwa, Toshihiro, Gemma, Akihiko, Yamamoto, Nobuyuki, Mizushima, Masaya, Ochai, Kaori, Ikeda, Rie, Azuma, Hisaya, Nakanishi, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687701/
https://www.ncbi.nlm.nih.gov/pubmed/31240497
http://dx.doi.org/10.1007/s10147-019-01488-w
_version_ 1783442759908065280
author Tamura, Kazuo
Nukiwa, Toshihiro
Gemma, Akihiko
Yamamoto, Nobuyuki
Mizushima, Masaya
Ochai, Kaori
Ikeda, Rie
Azuma, Hisaya
Nakanishi, Yoichi
author_facet Tamura, Kazuo
Nukiwa, Toshihiro
Gemma, Akihiko
Yamamoto, Nobuyuki
Mizushima, Masaya
Ochai, Kaori
Ikeda, Rie
Azuma, Hisaya
Nakanishi, Yoichi
author_sort Tamura, Kazuo
collection PubMed
description
format Online
Article
Text
id pubmed-6687701
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-66877012019-08-23 Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib Tamura, Kazuo Nukiwa, Toshihiro Gemma, Akihiko Yamamoto, Nobuyuki Mizushima, Masaya Ochai, Kaori Ikeda, Rie Azuma, Hisaya Nakanishi, Yoichi Int J Clin Oncol Correction Springer Singapore 2019-06-25 2019 /pmc/articles/PMC6687701/ /pubmed/31240497 http://dx.doi.org/10.1007/s10147-019-01488-w Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Tamura, Kazuo
Nukiwa, Toshihiro
Gemma, Akihiko
Yamamoto, Nobuyuki
Mizushima, Masaya
Ochai, Kaori
Ikeda, Rie
Azuma, Hisaya
Nakanishi, Yoichi
Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
title Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
title_full Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
title_fullStr Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
title_full_unstemmed Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
title_short Correction to: Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib
title_sort correction to: real-world treatment of over 1600 japanese patients with egfr mutation-positive non-small cell lung cancer with daily afatinib
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687701/
https://www.ncbi.nlm.nih.gov/pubmed/31240497
http://dx.doi.org/10.1007/s10147-019-01488-w
work_keys_str_mv AT tamurakazuo correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT nukiwatoshihiro correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT gemmaakihiko correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT yamamotonobuyuki correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT mizushimamasaya correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT ochaikaori correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT ikedarie correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT azumahisaya correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib
AT nakanishiyoichi correctiontorealworldtreatmentofover1600japanesepatientswithegfrmutationpositivenonsmallcelllungcancerwithdailyafatinib

Ejemplares similares